908 Devices director sells 20,000 shares
908 Devices Inc. director Christopher D. Brown reported an open-market sale of 20,000 shares of common stock at a weighted average price of $8.84 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
908 Devices Inc. director Christopher D. Brown reported an open-market sale of 20,000 shares of common stock at a weighted average price of $8.84 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 24, 2025.
Following this sale, Brown directly holds 845,559 shares of 908 Devices common stock. Because the sale was carried out pursuant to a Rule 10b5-1 plan, the timing reflects a preset trading arrangement rather than a discretionary decision based on recent company developments.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 20,000 | $8.84 | $177K |
Footnotes (2)
- F1. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2025.
- F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.61 to $8.95 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
AI-generated analysis. How Rhea-AI works. Not financial advice.